journal article·2024-11-20Open access

Strontium- and Copper-Doped Ceramic Granules in Bone Regeneration-Associated Cellular Processes

Yuliya Safarova (Yantsen), Assem Nessipbekova, Aizhan Syzdykova, Farkhad Olzhayev, Bauyrzhan Umbayev, Aliya Kassenova, Inna V. Fadeeva, Sholpan Askarova, Julietta V. Rau

Journal of Functional Biomaterials· Volume 15· Issue 11

Abstract

Background: Pathological bone fracturing is an escalating problem driven by increasing aging and obesity. Bioceramics, particularly tricalcium-phosphate-based materials (TCP), are renowned for their exceptional biocompatibility, osteoconductivity, and ability to promote biomineralization. In the present study, we designed and characterized TCP porous granules doped with strontium (Sr) and copper (Cu) (CuSr TCP). Sr2+ ions were selected as Sr plays a crucial role in early bone formation, osteogenesis, and angiogenesis; Cu2+ ions possess antibacterial properties. Materials: The synthesized CuSr TCP granules were characterized by X-ray diffraction. Cytotoxicity and cell proliferation analyses’ assays were performed through the lactate dehydrogenase (LDH) activity and CCK-8 viability tests in rat bone marrow-derived mesenchymal stem cells (BM-MSCs). Hemolytic activity was carried out with human red blood cells (RBCs). Early and late osteogenesis were assessed with alkaline phosphatase (ALP) and Alizarin Red S activity in human osteoblast progenitor cells and rat BM-MSCs. The influence of CuSr TCP on angiogenesis was investigated in human umbilical vein endothelial cells (HUVECs). Results: We have demonstrated that media enriched with CuSr TCP in concentrations ranging from 0.1 mg/mL to 1 mg/mL were not cytotoxic and did not significantly affect cell proliferation rate motility. Moreover, a concentration of 0.5 mg/mL showed a 2.5-fold increase in the migration potential of BM-MSCs. We also found that CuSr TCP-enriched media slightly increased early osteogenesis. We also found that Sr and Cu substitutions in TCP particles significantly enhanced the measured angiogenic parameters compared to control and unsubstituted TCP granules. Conclusion: Our results demonstrate that TCP porous granules doped with Sr and Cu are biocompatible, promote osteodifferentiation and angiogenesis, and could be recommended for further in vivo studies.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Bone Metabolism and Diseases · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

National Laboratory Astana, Nazarbayev University, Kabanbay batyr Ave. 53, 010000 Astana, Kazakhstan

A. A. Baikov Institute of Metallurgy and Material Science RAS, Leninskie, 49, 119334 Moscow, Russia

Instituto di Struttura della Materia, Consiglio Nazionale delle Ricerche, ISM-CNR, Via del Fosso del Cavaliere 100, 00133 Rome, Italy

Department of Analytical, Physical and Colloid Chemistry, Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University, Trubetskaya 8, Build. 2, 119048 Moscow, Russia

Funding

Ministry of Science and Higher Education of the Republic of Kazakhstan

References (75)

Show source-provided references
1. The economic burden of injury: Health care and productivity costs of injuries in the Netherlands10.1016/j.aap.2016.04.003 ↗
2. Fragility fractures in Europe: Burden, management and opportunities10.1007/s11657-020-0706-y ↗
3. GBD 2019 Fracture Collaborators (2021). Global, regional, and national burden of bone fractures in 204 countries and territories, 1990–2019: A systematic analysis from the Global Burden of Disease Study 2019. Lancet Health Longev., 2, e580–e592.
4. Costs of fragility hip fractures globally: A systematic review and meta-regression analysis10.1007/s00198-017-4153-6 ↗
5. Schlickewei, C.W., Kleinertz, H., Thiesen, D.M., Mader, K., Priemel, M., Frosch, K.-H., and Keller, J. (2019). Current and Future Concepts for the Treatment of Impaired Fracture Healing. Int. J. Mol. Sci., 20.10.3390/ijms20225805 ↗
6. Bone graft substitutes for the treatment of traumatic fractures of the extremities
7. Crispr strategies for stem cell engineering: A new frontier in musculoskeletal regeneration10.22203/eCM.v046a05 ↗
8. Treatment of critical-sized bone defects: Clinical and tissue engineering perspectives10.1007/s00590-017-2063-0 ↗
9. Bone Grafts in Trauma and Orthopaedics
10. Bone grafts and biomaterials substitutes for bone defect repair: A review
11. Sallent, I., Capella-Monsonís, H., Procter, P., Bozo, I.Y., Deev, R.V., Zubov, D., Vasyliev, R., Perale, G., Pertici, G., and Baker, J. (2020). The Few Who Made It: Commercially and Clinically Successful Innovative Bone Grafts. Front. Bioeng. Biotechnol., 8.10.3389/fbioe.2020.00952 ↗
12. Physical and monetary costs associated with autogenous bone graft harvesting
13. Calcium orthophosphates (CaPO4): Occurrence and properties10.1007/s40204-015-0045-z ↗
14. Comparative study on biodegradation and biocompatibility of multichannel calcium phosphate based bone substitutes10.1016/j.msec.2020.110694 ↗
15. Use of autogenous bone and beta-tricalcium phosphate in maxillary sinus lifting: Histomorphometric study and immunohistochemical assessment of RUNX2 and VEGF10.1016/j.ijom.2017.01.002 ↗
16. Recent Advances of Biphasic Calcium Phosphate Bioceramics for Bone Tissue Regeneration10.1007/978-981-15-3262-7_12 ↗
17. Lu, H., Zhou, Y., Ma, Y., Xiao, L., Ji, W., Zhang, Y., and Wang, X. (2021). Current Application of Beta-Tricalcium Phosphate in Bone Repair and Its Mechanism to Regulate Osteogenesis. Front. Mater., 8.10.3389/fmats.2021.698915 ↗
18. Jeong, J., Kim, J.H., Shim, J.H., Hwang, N.S., and Heo, C.Y. (2019). Bioactive calcium phosphate materials and applications in bone regeneration. Biomater. Res., 23.10.1186/s40824-018-0149-3 ↗
19. β-tricalcium phosphate for bone substitution: Synthesis and properties10.1016/j.actbio.2020.06.022 ↗
20. Long-term clinical outcomes following the use of synthetic hydroxyapatite and bone graft in impaction in revision hip arthroplasty10.1016/j.biomaterials.2008.12.035 ↗
21. Bone formation and resorption in patients after implantation of beta-tricalcium phosphate blocks with 60% and 75% porosity in opening-wedge high tibial osteotomy10.1002/jbm.b.31041 ↗
22. Maxillary sinus grafting with Bio-Oss or Straumann Bone Ceramic: Histomorphometric results from a randomized controlled multicenter clinical trial10.1111/j.1600-0501.2008.01565.x ↗
23. Bone regeneration with osteogenic matrix cell sheet and tricalcium phosphate: An experimental study in sheep10.5312/wjo.v8.i10.754 ↗
24. Mg2+, Sr2+, Ag+, and Cu2+ co-doped β-tricalcium phosphate: Improved thermal stability and mechanical and biological properties10.1111/jace.19093 ↗
25. Lebedev, V.N., Kharovskaya, M.I., Lazoryak, B.I., Solovieva, A.O., Fadeeva, I.V., Amirov, A.A., Koliushenkov, M.A., Orudzhev, F.F., Baryshnikova, O.V., and Yankova, V.G. (2024). Strontium and Copper Co-Doped Multifunctional Calcium Phosphates: Biomimetic and Antibacterial Materials for Bone Implants. Biomimetics, 9.10.3390/biomimetics9040252 ↗
26. Study of hMSC proliferation and differentiation on Mg and Mg–Sr containing biphasic β-tricalcium phosphate and amorphous calcium phosphate ceramics10.1016/j.msec.2016.03.020 ↗
27. Lithium release from β-tricalcium phosphate inducing cementogenic and osteogenic differentiation of both hPDLCs and hBMSCs10.1039/C4BM00111G ↗
28. Substituted hydroxyapatites for bone repair10.1007/s10856-012-4598-2 ↗
29. Resorbable Tricalcium Phosphates for Bone Tissue Engineering: Influence of SrO Doping10.1111/j.1551-2916.2012.05356.x ↗
30. Ferreira, M.M., Brito, A.F., Brazete, D., Pereira, I.C., Carrilho, E., Abrantes, A.M., Pires, A.S., Aguiar, M.J., Carvalho, L., and Botelho, M.F. (2018). Doping β-TCP as a Strategy for Enhancing the Regenerative Potential of Composite β-TCP-Alkali-Free Bioactive Glass Bone Grafts. Experimental Study in Rats. Materials, 12.10.3390/ma12010004 ↗
31. Strontium ranelate promotes osteoblastic cell replication through at least two different mechanisms10.1016/j.bone.2008.02.010 ↗
32. Effects of MgO, ZnO, SrO, and SiO2 in tricalcium phosphate scaffolds on in vitro gene expression and in vivo osteogenesis10.1016/j.msec.2018.10.073 ↗
33. Dual effect of strontium ranelate: Stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro10.1016/j.bone.2007.08.043 ↗
34. Sugimoto, H., Inagaki, Y., Furukawa, A., Kira, T., Kawasaki, S., Uchihara, Y., Akahane, M., and Tanaka, Y. (2021). Silicate/zinc-substituted strontium apatite coating improves the osteoinductive properties of β-tricalcium phosphate bone graft substitute. BMC Musculoskelet. Disord., 22.10.1186/s12891-021-04563-4 ↗
35. Preparation and Characterization of Nanocomposite Scaffolds (Collagen/β-TCP/SrO) for Bone Tissue Engineering10.1007/s13770-019-00184-0 ↗
36. Strontium doping stimulates the phase composition and evolution of β-tricalcium phosphate prepared by wet chemical method10.1016/j.jssc.2022.123732 ↗
37. Nisyrios, T., Karygianni, L., Fretwurst, T., Nelson, K., Hellwig, E., Schmelzeisen, R., and Al-Ahmad, A. (2020). High Potential of Bacterial Adhesion on Block Bone Graft Materials. Materials, 13.10.3390/ma13092102 ↗
38. A review of the biomaterials technologies for infection-resistant surfaces10.1016/j.biomaterials.2013.07.089 ↗
39. A review of the clinical implications of anti-infective biomaterials and infection-resistant surfaces10.1016/j.biomaterials.2013.07.048 ↗
40. Tricalcium Phosphate Ceramics Doped with Silver, Copper, Zinc, and Iron (III) Ions in Concentrations of Less Than 0.5 wt.% for Bone Tissue Regeneration10.1007/s12668-016-0386-7 ↗
41. Antibacterial and cell-friendly copper-substituted tricalcium phosphate ceramics for biomedical implant applications10.1016/j.msec.2021.112410 ↗
42. Osteoblastic cell responses and antibacterial efficacy of Cu/Zn co-substituted hydroxyapatite coatings on pure titanium using electrodeposition method10.1039/C4RA12118J ↗
43. Binary Doping of Strontium and Copper Enhancing Osteogenesis and Angiogenesis of Bioactive Glass Nanofibers while Suppressing Osteoclast Activity10.1021/acsami.7b06521 ↗
44. Strontium and copper co-substituted hydroxyapatite-based coatings with improved antibacterial activity and cytocompatibility fabricated by electrodeposition10.1016/j.ceramint.2016.04.110 ↗
45. Ghezzi, D., Graziani, G., Cappelletti, M., Fadeeva, I.V., Montesissa, M., Sassoni, E., Borciani, G., Barbaro, K., Boi, M., and Baldini, N. (2024). New strontium-based coatings show activity against pathogenic bacteria in spine infection. Front. Bioeng. Biotechnol., 12.10.3389/fbioe.2024.1347811 ↗
46. Rau, J.V., De Bonis, A., Curcio, M., Barbaro, K., Fosca, M., Fadeeva, I.V., Cardoso, G.C., Teghil, R., Slonskaya, T.K., and Zheng, Y. (2024). Coated Biodegradable Zinc Lithium Alloys: Development and Characterization of Co-Doped Strontium Copper Tricalcium Phosphate Coating for Antimicrobial Applications. Coatings, 14.10.3390/coatings14081073 ↗
47. Antimicrobial properties of co-doped tricalcium phosphates Ca3−2x(M’M’’)x(PO4)2 (M = Zn2+, Cu2+, Mn2+ and Sr2+)10.1016/j.ceramint.2022.06.237 ↗
48. Barinov, S.M., Fadeeva, I.V., Fomin, A.S., and Petrakova, N.V. (2015). Method of Producing Porous Ceramics from Calcium Phosphates for Treating Bone Tissue Defects. (2578435 C1), P.o.t.R.F.N., Available online: https://patents.google.com/patent/RU2578435C1/en.
49. Geekiyanage, N.M., Balanant, M.A., Sauret, E., Saha, S., Flower, R., Lim, C.T., and Gu, Y. (2019). A coarse-grained red blood cell membrane model to study stomatocyte-discocyte-echinocyte morphologies. PLoS ONE, 14.10.1371/journal.pone.0215447 ↗
50. In vitro cell migration and invasion assays
51. Nucleus pulposus cells regulate macrophages in degenerated intervertebral discs via the integrated stress response-mediated CCL2/7-CCR2 signaling pathway10.1038/s12276-024-01168-4 ↗
52. Interactions of nitrogen-donor biomolecules with copper(II) complexes in Tris buffer10.1080/00958972.2020.1730336 ↗
53. Analysis of Cell Viability by the Lactate Dehydrogenase Assay
54. Carpentier, G., Berndt, S., Ferratge, S., Rasband, W., Cuendet, M., Uzan, G., and Albanese, P. (2020). Angiogenesis Analyzer for ImageJ—A comparative morphometric analysis of “Endothelial Tube Formation Assay” and “Fibrin Bead Assay”. Sci. Rep., 10.10.1038/s41598-020-67289-8 ↗
55. Review Paper: Behavior of Ceramic Biomaterials Derived from Tricalcium Phosphate in Physiological Condition10.1177/0885328208096798 ↗
56. β-tricalcium phosphate and octacalcium phosphate composite bioceramic material for bone tissue engineering10.1177/0885328220903989 ↗
57. Copper promotes the migration of bone marrow mesenchymal stem cells via Rnd3-dependent cytoskeleton remodeling10.1002/jcp.28961 ↗
58. Migration critically meditates osteoblastic differentiation of bone mesenchymal stem cells through activating canonical Wnt signal pathway10.1016/j.colsurfb.2018.07.017 ↗
59. Strontium Promotes Osteogenic Differentiation of Mesenchymal Stem Cells Through the Ras/MAPK Signaling Pathway10.1159/000204105 ↗
60. Osteoblasts play key roles in the mechanisms of action of strontium ranelate10.1111/j.1476-5381.2009.00305.x ↗
61. The Calcium-sensing Receptor Is Involved in Strontium Ranelate-induced Osteoclast Apoptosis10.1074/jbc.M801668200 ↗
62. A review of the latest insights into the mechanism of action of strontium in bone10.1016/j.bonr.2020.100273 ↗
63. The calcium-sensing receptor in bone—Mechanistic and therapeutic insights10.1038/nrendo.2015.30 ↗
64. The Calcium-sensing Receptor (CaR) is Involved in Strontium Ranelate-induced Osteoblast Differentiation and Mineralization10.1055/s-0030-1255091 ↗
65. Strontium ranelate rebalances bone marrow adipogenesis and osteoblastogenesis in senescent osteopenic mice through NFATc/Maf and Wnt signaling10.1111/j.1474-9726.2012.00804.x ↗
66. Osteogenic differentiation of osteoblasts induced by calcium silicate and calcium silicate/β-tricalcium phosphate composite bioceramics10.1002/jbm.b.32688 ↗
67. In vitro osteogenic, angiogenic, and inflammatory effects of copper in β-tricalcium phosphate10.1557/adv.2018.686 ↗
68. Concentration-dependent osteogenic and angiogenic biological performances of calcium phosphate cement modified with copper ions10.1016/j.msec.2019.02.042 ↗
69. Improved osteogenesis and angiogenesis of a novel copper ions doped calcium phosphate cement10.1016/j.msec.2020.111032 ↗
70. RETRACTED: Copper-doped borosilicate bioactive glass scaffolds with improved angiogenic and osteogenic capacity for repairing osseous defects10.1016/j.actbio.2014.12.010 ↗
71. Evaluation of borate bioactive glass scaffolds as a controlled delivery system for copper ions in stimulating osteogenesis and angiogenesis in bone healing10.1039/C4TB01355G ↗
72. Effect of copper-doped silicate 13–93 bioactive glass scaffolds on the response of MC3T3-E1 cells in vitro and on bone regeneration and angiogenesis in rat calvarial defects in vivo10.1016/j.msec.2016.05.073 ↗
73. Fabrication of a Cu/Zn co-incorporated calcium phosphate scaffold-derived GDF-5 sustained release system with enhanced angiogenesis and osteogenesis properties10.1039/C8RA05441J ↗
74. Beta-tricalcium phosphate ceramic triggers fast and robust bone formation by human mesenchymal stem cells
75. Molecular mechanisms of biomaterial-driven osteogenic differentiation in human mesenchymal stromal cells10.1039/c3ib40027a ↗